首页 | 本学科首页   官方微博 | 高级检索  
     

芪黄明目胶囊对糖尿病小鼠视网膜保护作用及对VEGF表达的影响
引用本文:王宏涛,王超,朱慧明,魏刚,赵韶华,齐晓琳,张会欣. 芪黄明目胶囊对糖尿病小鼠视网膜保护作用及对VEGF表达的影响[J]. 中国中药杂志, 2012, 37(22): 3481-3485
作者姓名:王宏涛  王超  朱慧明  魏刚  赵韶华  齐晓琳  张会欣
作者单位:1. 河北以岭医药研究院,河北石家庄,050035
2. 河北省人民医院,河北石家庄,050051
3. 石家庄以岭药业股份有限公司,河北石家庄,050035
基金项目:国家重大新药创制科技重大专项(2010ZX09101-101);河北省中医药管理局科研计划项目(2011041)
摘    要:目的:观察芪黄明目胶囊对Ⅱ型糖尿病小鼠视网膜的保护作用及对VEGF表达的影响.方法:40只KK/UpjAy小鼠随机分为模型组、芪黄明目高、中、低剂量组(8.32,4.16,2.08 g·kg-1),另设10只C57BL/6小鼠对照组.灌胃给药3个月,观察一般情况,测定空腹血糖(FBG)及糖化血红蛋白(HbA1c);光镜及电镜观察视网膜形态学变化;Real-time PCR(qPCR)和Western blot法测定视网膜血管内皮生长因子(VEGF)、血管内皮生长因子受体-1(Flt-1)、血管内皮生长因子受体-2(Flk-1)表达.结果:芪黄明目胶囊能不同程度改善模型小鼠症状,降低FBG和HbAlc;改善视网膜病理损伤;降低视网膜VEGF,Flt-1,Flk-1 mRNA和蛋白的表达.结论:芪黄明目胶囊可抑制糖尿病小鼠视网膜VEGF,Flt-1,Flk-1的表达,干预VEGF-VEGFR信号转导通路,起到保护视网膜的作用.

关 键 词:芪黄明目胶囊  糖尿病视网膜病变  血管内皮生长因子  血管内皮生长因子受体
收稿时间:2012-02-03

Protective effect of Qihuang Mingmu capsule on retina of diabetic mice and its impact on VEGF expression
WANG Hong-tao,WANG Chao,ZHU Hui-ming,WEI Gang,ZHAO Shao-hu,QI Xiao-lin and ZHANG Hui-xin. Protective effect of Qihuang Mingmu capsule on retina of diabetic mice and its impact on VEGF expression[J]. China Journal of Chinese Materia Medica, 2012, 37(22): 3481-3485
Authors:WANG Hong-tao  WANG Chao  ZHU Hui-ming  WEI Gang  ZHAO Shao-hu  QI Xiao-lin  ZHANG Hui-xin
Affiliation:Hebei Yiling Medicine Institute, Shijiazhuang 050035, China;Hebei Provincial People's Hospital, Shijiazhuang 050051, China;Hebei Yiling Medicine Institute, Shijiazhuang 050035, China;Hebei Yiling Medicine Institute, Shijiazhuang 050035, China;Hebei Yiling Medicine Institute, Shijiazhuang 050035, China;Shijiazhuang Yiling Pharmaceutical Co., Ltd., Shijiazhuang 050035, China;Hebei Yiling Medicine Institute, Shijiazhuang 050035, China
Abstract:Objective:To investigate the protective effect of Qihuang Mingmu capsule (QHMM) on retina of diabetic mice and its impact on VEGF expression. Method:Forty KK/Upj-Ay mice were randomly divided into the model group and high, middle and low dose QHMM (8.32, 4.16, 2.08 g·kg-1) groups. Additional 10 C57BL/6 mice were selected as the control group. Mice were orally administered for three months. Their general appearance, fasting blood-glucose (FBG) and glycosylated hemoglobin (HbA1c) were observed. Pathological changes of retina were observed by light microscope and electron microscope. The expressions of vascular endothelial growth factor (VEGF), growth factor receptors-1 (Flt-1) and growth factor receptors-2 (Flk-1) were examined by Real-time PCR (qPCR) and Western blot. Result:QHMM could ameliorate the symptoms of diabetic mice to varying degrees, decrease FBG and HbA1c, alleviate pathological lesions of retina and decrease the expressions of VEGF, Flt-1, Flk-1 mRNA and protein. Conclusion:QHMM has the protective effect on diabetic retinopathy of mice by inhibiting the expressions of VEGF, Flt-1 and Flk-1 and intervening VEGF-VEGFR signal transduction pathway.
Keywords:Qihuang Mingmu capsule  diabetic retinopathy  vascular endothelial growth factor  vascular endothelial growth factor receptor
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号